Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Insulin and Levocarnitine

drug:

Insulin

supplement:

Levocarnitine

Research Papers that Mention the Interaction

The fasting BS-level was significantly lower after the treatment - 3.85 ± 0.43 vs. 4.76 ± 1.02 mmol/L; p <0.… increased (72.8 ± 43.2 vs. 35.2 ± 18.3 mcmol/L; p <0.05) Improving the oxidative processes in peripheral tissues, L-carnitine … insulin and ….
The International journal of artificial organs  •  2003  |  View Paper
l-carnitine supplementation was associated with a decrease in postprandial plasma glucose and insulin concentration, indicating an enhanced glucose tolerance.
Journal of animal physiology and animal nutrition  •  2009  |  View Paper
L-carnitine has also been shown to improve insulin sensitivity and elevate pyruvate dehydrogenase (PDH) flux.
Nutrients  •  2020  |  View Paper
L-carnitine decreased malondialdehyde, glucose, insulin , HbA1c and MuRF1 and increased ISI and antioxidants.
Journal of basic and clinical physiology and pharmacology  •  2018  |  View Paper
Contrary to our hypothesis, despite significant activation of PKB and 2DG uptake, insulin did not increase l-carnitine uptake at 100 nM. However, l-carnitine uptake was modestly increased at a dose of 150 nM insulin.
American journal of physiology. Cell physiology  •  2017  |  View Paper
Concomitant administration of L-carnitine increased plasma insulin concentrations, decreasing plasma glucose and HbA1c levels.
Transplantation proceedings  •  2013  |  View Paper
L-Carnitine supplementation significantly reduced FPG, insulin , HOMA-IR, and HbA1c levels.
L-carnitine supplementation resulted in a significant reduction in ….57; 95 % CI: -6.88, -2.25), insulin (WMD: -1.21; 95 % CI: -1.85, -0.57), homeostatic model assessment for insulin resistance (HOMA-…: -0.90, -0.44) and HbA1C concentrations (WMD: -0.30; 95 % CI: -0.47, -0.13).
EXCLI journal  •  2019  |  View Paper